News Powered By AI
News Powered By AI
Voya Financial reported declining second-quarter earnings amid severance costs, though its retirement and investment management segments showed strong asset growth and fee revenue increases.
Protagonist Therapeutics swung to a $162.8 million profit in the second quarter, boosted by milestone payments from its psoriasis drug ICOTYDE and the injectable rusfertide awaiting FDA approval.
Wynn Resorts reported second quarter net income more than doubling to $140.1 million, though profitability declined at three of four properties outside Macau’s strong performance.
Stock markets have experienced choppy trading with limited upside progress, yet the VIX volatility index continues declining, creating a disconnect that confuses market participants seeking to understand current conditions.
Murphy USA reported second-quarter net income of $209.1 million, up from $145.6 million a year earlier, driven by higher fuel margins and merchandise growth.
Alexandria Real Estate Equities reported narrowing net losses but saw funds from operations decline, with occupancy pressures offsetting strong leasing volume in the second quarter.
